Allergan Announces FDA Approval of Avycaz (ceftazidime and avibactam) for Pediatric Patients

Article Link: Allergan Announces FDA Approval of Avycaz (ceftazidime and avibactam) for Pediatric Patients

DUBLIN, March 18, 2019 /PRNewswire/ — Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental New Drug Application (sNDA) for Avycaz (ceftazidime and avibactam),…

Source: FDA New Drug Approvals